CAO Jian , QU Zheng.
  • Department of Cardiac Surgery, Beijing Anzhen Hospital, the Capital University of Medical Sciences, Beijing 100029, P.R. China;
Coronary artery bypass grafting; Restenosis; Great saphenous vein grafts
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Abstract: Coronary artery bypass grafting (CABG) is one of the conventional treatments of coronary artery disease. Though the artery grafts have its own superiority, autologous great saphenous vein is still commonly used. Ten years after operation, half of the vein grafts will be occluded and half of the remainder will often undergo severe pathological conditions. The poor long term patency of vein grafts has become the bottleneck of the efficiency of CABG. The restenosis of vein grafts resulting from neointima and atherosclerosis has become an urgent problem waiting to be resolved. As the study on the molecular mechanism and pathophysiology of the vein grafts disease develops, many therapeutic schedules have been made, including drug therapy, external stent, expanding solution and gene therapy. By contrast, gene therapy has a broader prospect. This article will have a review on the prevention of restenosis of the vein grafts after CABG.

Citation： CAO Jian,QU Zheng.. The Prevention of Restenosis in Vein Grafts after Coronary Artery Bypass Grafting. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2010, 17(6): 499-502. doi: Copy